(New York, NY) – November 10, 2015 – AiCure, a leading artificial intelligence company in healthcare, has been awarded its eleventh patent titled “Apparatus and Method for Collection of Protocol Adherence Data” by the United States Patent and Trademark Office. US patent 9,183,601 issued on November 10, 2015 protects AiCure’s artificial intelligence platform, and its unique method for collecting real-time medication adherence data. This newly awarded patent, as well as others in the AiCure portfolio, protects the platform in its ability to monitor and ensure correct medication ingestion.
AiCure has been pursuing an aggressive development and protection program for its critical intellectual property assets since 2009. With US and global patent applications already filed and issued, and additional technology in the process of being protected, these critically important assets are at the forefront for AiCure.